Moreover, it has been revealed that SCD1 increases colorectal cancer (CRC) progression through promoting epithelial-mesenchymal transition (EMT), promoting metastasis of CRC cells through MUFA production and suppressing PTEN in response to glucose [20]. This evidence concerns the gene SCD and colorectal carcinoma.